Medical Condition News

RSS

Scientists avert drug resistance in subtype of brain tumors

In far too many cases over the years, scientists have discovered promising new cancer treatments, only to report later that the tumor cells found ways to become resistant. These disappointing results have made overcoming drug resistance a major goal in cancer research.

11 Feb 2021

New gut microbiome-based approach may have translational potential for cancer immunotherapy

Scientists from Nanjing University and the University of Macau have devised a new approach to extend the survival of transplanted probiotics in vivo, enhancing the efficacy of cancer chemo-/immunotherapies in mice.

11 Feb 2021

A new method to determine how carcinogenic bacteria reach their targets

The gram-negative bacteria Helicobacter pylori (H. pylori) colonize the stomachs of the majority of the world's population.

11 Feb 2021

Cell-selective nanotherapy can help treat atherosclerotic plaques

Percutaneous coronary intervention (PCI), commonly known as angioplasty with a stent, opens clogged arteries and saves lives. Despite its benefit in treating atherosclerosis that causes coronary artery disease, this common minimally-invasive procedure still poses severe complications for some patients.

11 Feb 2021

Single strain of bacteria may reduce the severity of graft-versus-host disease

MUSC Hollings Cancer Center researchers found that a single strain of bacteria may be able to reduce the severity of graft-versus-host disease (GVHD), as reported online in February 2021 in JCI Insight.

11 Feb 2021

Researchers analyze overall survival rate of prostate cancer patients treated with melatonin

Oncotarget recently published "Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment" which reported that a retrospective study included 955 patients of various stages of prostate cancer who received combined hormone radiation treatment from 2000 to 2019.

11 Feb 2021

Researchers use cachexia model to assess cancer-derived myocardial impairments

Oncotarget recently published "Evaluation of cancer-derived myocardial impairments using a mouse model" which reported that Myocardial damage in cancer patients is emphasized as a cause of death; however, there are not many murine cachexia models to evaluate cancer-derived heart disorder.

11 Feb 2021

New research examines how alcohol exposure impacts aspects of neuroplasticity

New research and analysis examine how alcohol exposure impacts many aspects of neuroplasticity in a special issue of Brain Plasticity

11 Feb 2021

New strategy to optimize the efficacy of neuropeptides for therapeutic applications

Dimerization (Note: combination of two identical or different molecules) of the human neuropeptides oxytocin and vasopressin can produce new types of bioactive molecules.

10 Feb 2021

Study could help develop drugs for pregnancy maintenance, treat autoimmune diseases

A team of scientists from Immanuel Kant Baltic Federal University with their colleagues from the Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences (Perm) studied the effect of trophoblastic β1-glycoprotein in the blood of pregnant women on pro-inflammatory immune cells.

10 Feb 2021

Study identifies new therapeutic targets for treatment of obesity and type 2 diabetes

The GIP receptor in the central nervous system plays a crucial role in the regulation of body weight and food intake.

10 Feb 2021

Virtual reality app can help reduce fear of heights

Researchers from the University of Basel have developed a virtual reality app for smartphones to reduce fear of heights.

10 Feb 2021

Researchers find higher odds of hospital readmission after endovascular aneurysm repair

Ruptured abdominal aortic aneurysms (rAAA) are responsible for nearly 2% of all deaths in U.S. men over the age of 65.

10 Feb 2021

Long-term stress is a risk factor for heart attacks, study suggests

Can long-term stress lead to heart attacks? Most people would probably answer in the affirmative, but the scientific evidence of this is scarce.

10 Feb 2021

Pandemic-fueled alcohol abuse creates wave of hospitalizations for liver disease

As the pandemic sends thousands of recovering alcoholics into relapse, hospitals across the country have reported dramatic increases in alcohol-related admissions for critical diseases like alcoholic hepatitis and liver failure.

10 Feb 2021

Inherited genetic variation may affect the response to cancer immunotherapy

For all their importance as a breakthrough treatment, the cancer immunotherapies known as checkpoint inhibitors still only benefit a small minority of patients, perhaps 15 percent across different types of cancer.

10 Feb 2021

Study unravels function of 'mystery protein' that kills brain cells of people with Parkinson's

A study published in Nature Communications today (Wednesday 10 February) presents compelling new evidence about what a key protein called alpha-synuclein actually does in neurons in the brain.

10 Feb 2021

MD Anderson and Mirati Therapeutics collaborate to expand evaluation of potent KRAS inhibitors

The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development collaboration to expand the evaluation of Mirati's two investigational small molecules, potent and selective KRAS inhibitors - adagrasib (MRTX849), a G12C inhibitor in clinical development, and MRTX1133, a G12D inhibitor in preclinical development, as monotherapy and in combination with other agents - which target two of the most frequent KRAS mutations in cancer.

10 Feb 2021

Study finds increasing death rates from heart disease in young women

A nationwide US study has found increasing death rates from heart disease in women under 65. The research is published in European Heart Journal - Quality of Care and Clinical Outcomes, a journal of the European Society of Cardiology (ESC).

10 Feb 2021

Reducing obesity may prevent up to half of new type 2 diabetes cases

Reducing the prevalence of obesity may prevent up to half of new Type 2 diabetes cases in the United States, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

10 Feb 2021

Medical Condition News

Scientists avert drug resistance in subtype of brain tumors

New gut microbiome-based approach may have translational potential for cancer immunotherapy

A new method to determine how carcinogenic bacteria reach their targets

Cell-selective nanotherapy can help treat atherosclerotic plaques

Single strain of bacteria may reduce the severity of graft-versus-host disease

Researchers analyze overall survival rate of prostate cancer patients treated with melatonin

Researchers use cachexia model to assess cancer-derived myocardial impairments

New research examines how alcohol exposure impacts aspects of neuroplasticity

New strategy to optimize the efficacy of neuropeptides for therapeutic applications

Study could help develop drugs for pregnancy maintenance, treat autoimmune diseases

Study identifies new therapeutic targets for treatment of obesity and type 2 diabetes

Virtual reality app can help reduce fear of heights

Researchers find higher odds of hospital readmission after endovascular aneurysm repair

Long-term stress is a risk factor for heart attacks, study suggests

Pandemic-fueled alcohol abuse creates wave of hospitalizations for liver disease

Inherited genetic variation may affect the response to cancer immunotherapy

Study unravels function of 'mystery protein' that kills brain cells of people with Parkinson's

MD Anderson and Mirati Therapeutics collaborate to expand evaluation of potent KRAS inhibitors

Study finds increasing death rates from heart disease in young women

Reducing obesity may prevent up to half of new type 2 diabetes cases

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News